Ultra-fast HPLC-ICP-MS analysis of oxaliplatin in patient urine
- 362 Downloads
A novel method for rapid HPLC-ICP-MS analysis of oxaliplatin in human urine was developed implementing a stationary HPLC phase with a particle size of 1.8 µm. The method allowed a cycle time of <1 min at a HPLC flow rate of 0.9 mL min−1. Procedural limits of detection of 0.05 µg L−1 oxaliplatin (150 fg on column) were obtained. Analysis of oxaliplatin in patient urine showed that accurate quantification of the intact drug demanded for storage at −80 °C and rapid measurement after thawing.
KeywordsOxaliplatin HPLC ICP-MS
Financial support was granted through the Austrian Science Fund (FWF-Project P16089-N03: “Speciation of cancerostatic Pt compounds in the environment”). Prof. Mader (Vienna University Hospital) is gratefully acknowledged for sampling of patient urine. Thomas Falta is acknowledged for performing the HILIC-ICP-MS measurements.
- 1.Graham MA, Lockwood GF, Greenslade D, Brienza S, Bayssas M, Gamelin E (2000) Clin Cancer Res 6:1205–1218Google Scholar
- 5.Majors RE (2006) LC-GC Europe 19:352–362Google Scholar
- 7.Analytical Methods Technical Committee of the Chemistry Manufacturing Controls Coordinating Committee (CMC CC) of the Center for Drug Evaluation and Research at the Food and Drug Administration, Reviewer Guidance “Validation of Chromatographic Methods”, 1994, page 22.Google Scholar
- 11.Graham MA, Lockwood GF, Greenslade D, Brienza S, Bayssas M, Gamelin E (2000) Clin Cancer Res 2000:1205–1218Google Scholar
- 12.Allain P, Heudi O, Cailleux A, Le Bouil A, Larra F, Boisdron-Celle M, Gamelin E (2000) Drug Metab Dispos 28:1379–1384Google Scholar
- 15.EURACHEM (2000) Quantifying uncertainty in analytical measurement, 2nd edn. UK, LondonGoogle Scholar